Quality key factors
Factor
Value
Sales Growth (5y)
4.40%
EBIT Growth (5y)
-6.62%
EBIT to Interest (avg)
0.72
Debt to EBITDA (avg)
0.76
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.02
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
0.15%
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
22
Price to Book Value
1.06
EV to EBIT
-54.58
EV to EBITDA
-54.58
EV to Capital Employed
1.07
EV to Sales
54.58
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.92%
ROE (Latest)
-1.29%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
Technical Movement
0What is working for the Company
NO KEY POSITIVE TRIGGERS
-2What is not working for the Company
PBDIT(Q)
Lowest at Rs -0.54 cr.
PBT LESS OI(Q)
Lowest at Rs -0.54 cr.
Loading Valuation Snapshot...
Here's what is not working for Biogen Pharma
Operating Profit (PBDIT) - Quarterly
Lowest at Rs -0.54 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -0.54 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)